Corbus Pharmaceuticals Holdings Inc

CRBP NASDAQ Santé & Biotech États-Unis US21833P1030
10.02 $
9.16 %

Corbus Pharmaceuticals Holdings Inc est axée sur le développement de médicaments anti-inflammatoires pour le traitement de maladies rares et graves.

Performance & Momentum

6 Months 16.57 %
1 Year 29.12 %
3 Years 0.60 %
5 Years 81.13 %

Similar stocks to Corbus Pharmaceuticals Holdings Inc

Anantys Community

Be the first to share your analysis on Corbus Pharmaceuticals Holdings Inc.

Take control
of your investments

Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.

  • Real-time multi-portfolio tracking
  • AI analysis of your positions
  • Counter your cognitive biases